Artículos por temáticas

Definitions and symptoms of the post-COVID syndrome: an updated systematic umbrella review

Gutzeit J, Weiß M, Nürnberger C, Lemhöfer C, Appel KS, Pracht E, Reese JP, Lehmann C, Polidori MC, Hein G, Deckert J.

Eur Arch Psychiatry Clin Neurosci. 2025 Feb;275(1):129-140. doi: 10.1007/s00406-024-01868-y. Epub 2024 Jul 25.

Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responses

Li X, Edén A, Malwade S, Cunningham JL, Bergquist J, Weidenfors JA, Sellgren CM, Engberg G, Piehl F, Gisslen M, Kumlien E, Virhammar J, Orhan F, Rostami E, Schwieler L, Erhardt S.

Brain Behav Immun. 2025 Feb;124:163-176. doi: 10.1016/j.bbi.2024.11.031. Epub 2024 Nov 29.

Neurological side effects of SARS-CoV-2 vaccination are common and can be severe

Finsterer J.

Brain Behav Immun Health. 2024 Dec 11;43:100921. doi: 10.1016/j.bbih.2024.100921. eCollection 2025 Feb.

Exploring the long-term neurological consequences of COVID-19

Wood H.

Nat Rev Neurol. 2025 Feb;21(2):65. doi: 10.1038/s41582-025-01056-z.

Navigating neurologic post-COVID-19 conditions in adults: Management strategies for cognitive dysfunction, headaches and neuropathies

Chopra A, Franko N, Chow EJ.

Life Sci. 2025 Feb 1;362:123374. doi: 10.1016/j.lfs.2025.123374. Epub 2025 Jan 5.

Hepatic phenomena associated with SARS-CoV-2: Acute liver injury, autoimmune hepatitis and post-vaccination

Mataix RP, Morillo JSG, Martín JMS.

Med Clin (Barc). 2025 Feb 4:S0025-7753(25)00011-9. doi: 10.1016/j.medcli.2024.12.006. Online ahead of print.

The relationship between microRNAs and COVID-19 complications

Kebriaei A, Besharati R, Namdar Ahmad Abad H, Havakhah S, Khosrojerdi M, Azimian A.

Noncoding RNA Res. 2024 Aug 22;10:16-24. doi: 10.1016/j.ncrna.2024.08.007. eCollection 2025 Feb.

The expanding clinical and genetic spectrum of DYNC1H1-related disorders

Möller B, Becker LL, Saffari A, Afenjar A, Coci EG, Williamson R, Ward-Melver C, Gibaud M, Sedláčková L, Laššuthová P, Libá Z, Vlčková M, William N, Klee EW, Gavrilova RH, Lévy J, Capri Y, Scavina M,

Brain. 2025 Feb 3;148(2):597-612. doi: 10.1093/brain/awae183.

Previous immunological disease can promote neurological complications of SARS-CoV-2 infection, such as VST or GBS

Finsterer J.

Future Sci OA. 2025 Dec;11(1):2463849. doi: 10.1080/20565623.2025.2463849. Epub 2025 Feb 10.

Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review

Zhao Y, Tang Y, Wang QY, Li J.

Front Immunol. 2025 Feb 4;16:1515768. doi: 10.3389/fimmu.2025.1515768. eCollection 2025.

Reply to the letter to the editor: previous immunological disease can promote neurological complications of SARS-CoV-2 infection, such as VST or GBS

Ayadi S, Jamoussi H.

Future Sci OA. 2025 Dec;11(1):2463851. doi: 10.1080/20565623.2025.2463851. Epub 2025 Feb 17.

Pediatric Wernicke Encephalopathy: A Systematic Review

Oudman E, Wijnia JW, Bidesie JR, van Dam MJ, Oey MJ, Smits S, van Dorp M, Postma A.

Pediatr Rep. 2025 Jan 30;17(1):15. doi: 10.3390/pediatric17010015.

Hyperthermia and targeting heat shock proteins: innovative approaches for neurodegenerative disorders and Long COVID

Smadja DM, Abreu MM.

Front Neurosci. 2025 Feb 4;19:1475376. doi: 10.3389/fnins.2025.1475376. eCollection 2025.

Guillain-Barré syndrome (GBS) after severe/critical COVID-19 or COVID-19 vaccination

Bahrami S, Ansari B, Norouzi-Barough L, Bagherpour B, Khorvash F, Shirani K, Abbasi S, Sherkat R.

Eur J Med Res. 2025 Feb 24;30(1):131. doi: 10.1186/s40001-025-02378-w.

Focusing on post-COVID syndrome fatigue

Gómez-Eguílaz M, López-Alava S, Ramón-Trapero JL, Castillo-Álvarez F, Gómez Loizaga N, García-Penco C, Boukichou-Abdelkader N, Pérez-Martínez L.

Neurologia (Engl Ed). 2025 Feb 11:S2173-5808(25)00004-5. doi: 10.1016/j.nrleng.2025.02.002. Online ahead of print.